<DOC>
	<DOCNO>NCT01115972</DOCNO>
	<brief_summary>This study assess effect ASP1585 pharmacokinetics valsartan 2x2 crossover method</brief_summary>
	<brief_title>A Study Assess Effect ASP1585 Pharmacokinetics Valsartan Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Valsartan</mesh_term>
	<criteria>Body weight : = &lt; 50.0kg , &lt; 80.0kg Body mass index : = &lt; 17.6 , &lt; 26.4 Healthy judge investigator caregiver subjective objective symptom physical examination data Attending another clinical trial within 120 day study Blood donation within 90 day ( 400ml ) 30 day ( 200ml ) study Receiving drug within 7 day study History allergy drug Having GI disorder History complication liver diseases History complication heart disease History complication respiratory diseases History complication renal disease History complication cerebrovascular disease</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>ASP1585</keyword>
	<keyword>Drug-drug interaction</keyword>
	<keyword>valsartan</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>